Late intra-patient tacrolimus trough level variability as a major problem in kidney transplantation: a collaborative transplant study report

Intra-patient variability (IPV) of tacrolimus trough level has been associated with poor outcome after kidney transplantation. These findings were derived from single-center analyses and restricted mainly to measurements early after transplantation. We analyzed in a multicenter effort whether high I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Süsal, Caner (VerfasserIn) , Döhler, Bernd (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 March 2019
In: American journal of transplantation
Year: 2019, Jahrgang: 19, Heft: 10, Pages: 2805-2813
ISSN:1600-6143
DOI:10.1111/ajt.15346
Online-Zugang:Verlag, Volltext: https://doi.org/10.1111/ajt.15346
Verlag: https://onlinelibrary.wiley.com/doi/abs/10.1111/ajt.15346
Volltext
Verfasserangaben:Caner Süsal, Bernd Döhler
Beschreibung
Zusammenfassung:Intra-patient variability (IPV) of tacrolimus trough level has been associated with poor outcome after kidney transplantation. These findings were derived from single-center analyses and restricted mainly to measurements early after transplantation. We analyzed in a multicenter effort whether high IPV of tacrolimus levels at posttransplant years 1, 2, and 3 was associated with impaired clinical outcome. More than 6600 patients who received a deceased donor kidney transplant during 2000-2014 and had a functioning graft for >3 years were studied. Graft survival was significantly impaired with increasing IPV (P < 0.001). As compared to patients with a low IPV of <30%, the risk of graft loss during years 4-6 increased 32% in patients with an IPV of 30% to 44% and 66% in patients with an IPV of ≥45% (P = 0.002 and P < 0.001). About one-third of patients showed an IPV of ≥30% with substantially impaired outcome. Even in patients with good outcome during the first 3 posttransplant years, a high IPV was associated with inferior graft survival. Our data indicate that a fluctuating tacrolimus trough level at years 1, 2, and 3 posttransplant is a major problem in kidney transplantation.
Beschreibung:Gesehen am 28.10.2019
Beschreibung:Online Resource
ISSN:1600-6143
DOI:10.1111/ajt.15346